Thioraviroc

塞拉维诺

Report date: 2026/02/03 10:28:18
NME

Base Information

Drug NameThioraviroc
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMultiple SclerosisHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHangzhou Minsheng Pharmaceutical Co LtdKunming Institute Of Zoology, Chinese Academy Of SciencesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisMultiple SclerosisHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A